[DPRX] Dipexium Pharmaceuticals, Inc.
Overview
Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
Market Capitalization:
Exchange: NASDAQ
The data is delayed by 15 minutes.
Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max
Chart type: absolute | relative to S&P
Description: Dipexium Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of antibiotics for the treatment of infectious diseases. It develops Locilex (pexiganan cream 0.8%), a novel, broad spectrum, and topical antibiotic, which is in phase 3 clinical trials for the treatment of mild infections of diabetic foot ulcers. The company was founded in 2010 and is based in New York, New York.
Fundamental Ratios
| Shares Outstanding | EPS | EPS Growth - 4 Quarters | EPS Growth - Q/Q | ||||
| EPS Growth - Y/Y | Sales Growth - 4 Quarters | Sales Growth - Q/Q | P/E | ||||
| P/E To EPS Growth | P/S | P/BV | Price/Cash Per Share | ||||
| Price/Free Cash Flow | ROA | -62.96% | ROE | -64.83% | ROI | ||
| Current Ratio | 34.57 | Quick Ratio | Long Term Debt/Equity | Debt Ratio | 0.03 | ||
| Gross Margin | Operating Margin | Net Profit Margin | Dividend Payout Ratio | ||||
| Dividend Yield |
Fundamental Data
| Cash From Financing Activities | Cash From Investing Activities | Cash From Operating Activities | -3.04 M | Gross Profit | |||
| Net Profit | -4.19 M | Operating Profit | -4.19 M | Total Assets | 24.18 M | Total Current Assets | 24.13 M |
| Total Current Liabilities | 700 K | Total Debt | Total Liabilities | 700 K | Total Revenue |
Technical Data
| High 52 week | 16.5 | Low 52 week | 1.1 | Last close | 1.34 | Last change | 0% |
| RSI | 40.83 | Average true range | 0.15 | Beta | 0.28 | Volume | 6.94 M |
| Simple moving average 20 days | 1.16% | Simple moving average 50 days | 3.55% | Simple moving average 200 days | -75.65% |
Performance Data
| Performance Week | 0% | Performance Month | 2.92% | Performance Quart | -10.8% | Performance Half | -43.06% |
| Performance Year | -89.25% | Performance Year-to-date | -16.38% | Volatility daily | 4.26% | Volatility weekly | 9.54% |
| Volatility monthly | 19.54% | Volatility yearly | 67.7% | Relative Volume | 3996.42% | Average Volume | 94.65 K |
| New High | New Low |
News
2017-04-24 09:20:13 | Houston real estate, energy, pharma cos. close more than $2B in deals
2017-04-18 05:00:44 | Dipexium Pharmaceuticals posts 1Q loss
2017-02-14 07:30:00 | PLx Pharma Announces Publication of Positive Antiplatelet Data for Aspertec in Peer-Reviewed Medical Journal JACC
2017-01-26 13:04:06 | DIPEXIUM PHARMACEUTICALS, INC. Financials
2017-01-25 17:36:00 | SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Dipexium Pharma - DPRX
2017-01-20 16:13:20 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
2016-12-22 17:56:39 | Dipexium shares surge on announced merger with PLx Pharma
2016-12-22 16:51:26 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Changes in Control or
2016-12-22 16:48:14 | Dipexium and PLx Pharma Announce Merger Agreement
2016-12-22 16:40:00 | 4:40 pm Dipexium Pharmaceuticals announces merger with PLx Pharma shares halted
2016-12-22 16:39:00 | Dipexium and PLx Pharma Announce Merger Agreement
2016-12-14 16:06:47 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements an
2016-12-14 01:34:51 | Is Dipexium Pharmaceuticals Inc DPRX A Good Stock To Buy?
2016-11-16 16:06:40 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
2016-11-10 07:11:23 | Dipexium Pharmaceuticals posts 3Q loss
2016-11-10 07:11:07 | Dipexium Pharmaceuticals Reports Third Quarter 2016 Financial Results
2016-11-10 07:00:00 | Dipexium Pharmaceuticals Reports Third Quarter 2016 Financial Results
2016-11-09 16:09:29 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
2016-10-31 16:08:02 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
2016-10-29 09:45:55 | 6 Companies That Destroyed Shareholders Last Week
2016-10-26 08:15:00 | Blog Coverage Dipexium Stock Tanks on Trial Failure
2016-10-25 16:09:00 | Is This the Beginning of the End of a Dipexium Implosion?
2016-10-25 16:07:00 | Dipexium Foot Ulcer Study Fails Big Time DPRX
2016-10-25 16:04:01 | Ericsson, Nike Drop in on Tuesday’s 52-Week Low Club
2016-10-25 12:32:35 | Blackberry BBRY’s Swan Song, Bear Attacks and Failed Drugs: 5 Stocks Getting Mauled by the Market Today
2016-10-25 11:35:56 | Dipexium Pharmaceuticals downgraded by Feltl & Co.
2016-10-25 08:22:22 | Dipexium's stock plunges in active trade after trial fails trials
2016-10-20 07:08:09 | Dipexium Provides Update on Availability of Results from Pivotal Phase 3 Clinical Trials with Locilex®
2016-10-20 07:00:00 | Dipexium Provides Update on Availability of Results from Pivotal Phase 3 Clinical Trials with Locilex®
2016-10-04 08:48:02 | Dipexium Receives European Medicines Agency Designation as a Small and Medium Enterprise
2016-10-04 08:00:00 | Dipexium Receives European Medicines Agency Designation as a Small and Medium Enterprise
2016-09-28 08:45:12 | Dipexium Pharmaceuticals DPRX Worth a Look: Stock Up 8.8%
2016-09-16 12:41:03 | Dipexium Pharmaceuticals, Inc. :DPRX-US: Earnings Analysis: Q2, 2016 By the Numbers : September 16, 2016
2016-09-07 08:09:10 | Dipexium Pharmaceuticals Announces Issuance of Locilex® Patent by European Union
2016-09-07 08:00:00 | Dipexium Pharmaceuticals Announces Issuance of Locilex® Patent by European Union
2016-09-01 08:45:12 | Dipexium Pharmaceuticals DPRX in Focus: Stock Gains 8.5%
2016-08-24 08:18:10 | Dipexium Pharmaceuticals Announces Participation in September Investor Conferences
2016-08-24 08:00:00 | Dipexium Pharmaceuticals Announces Participation in September Investor Conferences
2016-08-11 13:04:30 | DIPEXIUM PHARMACEUTICALS, INC. Financials
2016-08-04 07:22:16 | Dipexium Pharmaceuticals Reports Second Quarter 2016 Financial Results
2016-08-04 07:03:29 | Dipexium Pharmaceuticals posts 2Q loss
2016-08-04 07:00:00 | Dipexium Pharmaceuticals Reports Second Quarter 2016 Financial Results
2016-07-28 07:18:06 | Dipexium Pharmaceuticals to Hold Second Quarter 2016 Financial Results Conference Call on Thursday, August 4, 2016, at 8:30 a.m. ET
2016-07-28 07:00:00 | Dipexium Pharmaceuticals to Hold Second Quarter 2016 Financial Results Conference Call on Thursday, August 4, 2016, at 8:30 a.m. ET
2016-06-20 16:09:05 | Dipexium Pharmaceuticals' Locilex® Microbiology Data Presented at ASM Microbe 2016 Conference
2016-06-20 16:01:00 | Dipexium Pharmaceuticals' Locilex® Microbiology Data Presented at ASM Microbe 2016 Conference
2016-06-06 14:33:13 | Dipexium Pharmaceuticals, Inc. :DPRX-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016
2016-05-16 08:32:08 | Dipexium Announces Completion of Enrollment Objective in OneStep-1 Pivotal Phase 3 Clinical Trial